Oxygen Toxicity: Causes, Symptoms, and Clinical Management

Oxygen is essential for cellular metabolism, tissue function, and survival, but excessive exposure can cause significant injury. Oxygen toxicity develops when the concentration or partial pressure of oxygen remains elevated long enough to overwhelm the body’s protective mechanisms.

The lungs are most commonly affected during conventional oxygen therapy, while the central nervous system may be injured during hyperbaric exposure.

Safe oxygen administration requires balancing the immediate danger of hypoxemia against the cumulative risks of hyperoxia, pulmonary inflammation, alveolar collapse, impaired gas exchange, and damage to developing tissues.

What Is Oxygen Toxicity?

Oxygen toxicity is tissue injury caused by exposure to an excessive concentration or partial pressure of oxygen. It is often called hyperoxic lung injury when the lungs are primarily affected. The condition is dose-dependent, meaning that both the amount of oxygen delivered and the duration of exposure influence the likelihood of injury.

A patient may tolerate a moderately elevated oxygen concentration for a relatively long period without obvious complications. In contrast, exposure to a very high oxygen concentration may cause injury more quickly. There is no single oxygen concentration or exposure time that produces toxicity in every patient. Individual susceptibility varies according to age, underlying disease, inflammatory state, nutritional status, antioxidant capacity, and severity of illness.

Oxygen toxicity should not be confused with the appropriate use of high oxygen concentrations during an emergency. A patient with severe hypoxemia may require an inspired oxygen concentration approaching 100%. In that situation, the immediate risk of inadequate tissue oxygenation is greater than the delayed risk of toxicity. The concern develops when high oxygen concentrations are continued longer than clinically necessary.

Oxygen as a Medication

Oxygen should be treated like any other medication. It has specific indications, a measurable dose, therapeutic goals, and possible adverse effects. Oxygen therapy should therefore be prescribed, monitored, and adjusted according to the patient’s condition.

The dose of oxygen may be described by:

• The fraction of inspired oxygen, or FiO₂
• The oxygen flow rate
• The arterial oxygen tension, or PaO₂
• The oxygen saturation measured by pulse oximetry, or SpO₂
• The partial pressure of oxygen under hyperbaric conditions

A higher oxygen saturation is not always better. Once hemoglobin is adequately saturated, further increases in PaO₂ produce only a small increase in arterial oxygen content. Maintaining an unnecessarily high PaO₂ may increase oxygen exposure without meaningfully improving tissue oxygen delivery.

The goal of oxygen therapy is not to produce the highest possible oxygen value. The goal is to provide enough oxygen to support cellular metabolism and organ function while limiting avoidable hyperoxia.

Hyperoxia and Its Physiologic Effects

Hyperoxia generally refers to an arterial oxygen level above the normal physiologic range. Although definitions vary, the clinical concern is that elevated PaO₂ values can produce adverse effects even before extremely high levels are reached.

Excessive arterial oxygen may cause vasoconstriction in several vascular beds. This can reduce blood flow to the brain, coronary circulation, and skeletal muscles. Hyperoxia may also lower cardiac output in some patients. These changes can potentially reduce tissue perfusion even when the measured arterial oxygen level appears more than adequate.

The effect of hyperoxia on oxygen delivery depends on more than PaO₂ alone. Tissue oxygen delivery is influenced by:

• Hemoglobin concentration
• Hemoglobin saturation
• Cardiac output
• Regional blood flow
• Cellular oxygen extraction
• Metabolic demand

A patient may have a high PaO₂ but still have inadequate tissue oxygen delivery if cardiac output is poor or severe anemia is present. Conversely, a patient may have a lower PaO₂ but adequate oxygen delivery when hemoglobin concentration, cardiac output, and tissue perfusion are sufficient.

How Oxygen Toxicity Develops

The primary mechanism of oxygen toxicity involves the excessive production of reactive oxygen species. These unstable molecules are formed naturally during cellular metabolism, but high oxygen exposure increases their production beyond the capacity of normal antioxidant defenses.

Reactive Oxygen Species

Reactive oxygen species include several chemically active molecules, such as:

• Superoxide radicals
• Hydrogen peroxide
• Hydroxyl radicals
• Perhydroxyl radicals
• Other oxygen-derived free radicals

Under normal conditions, antioxidant systems neutralize these substances before they cause significant cellular injury. Important antioxidant defenses include superoxide dismutase, catalase, glutathione, and other enzymes or molecules that reduce oxidative stress.

When oxygen concentrations remain elevated, reactive oxygen species may be generated faster than the body can remove them. The resulting oxidative stress damages cell membranes, proteins, enzymes, lipids, mitochondria, and genetic material.

Failure of Antioxidant Defenses

Alveolar type II cells play an important role in defending the lungs against oxidative injury. These cells produce surfactant and contain antioxidant enzymes that help neutralize oxygen-derived free radicals.

Prolonged hyperoxia can damage type II cells. As these cells become dysfunctional or die, the lungs lose part of their antioxidant protection. Surfactant production may also decline. The combination of reduced antioxidant activity and impaired surfactant production makes the alveoli increasingly vulnerable to injury and collapse.

Oxidative damage may therefore become self-perpetuating. Initial exposure injures the cells that normally protect the lungs, which reduces the ability to tolerate continued oxygen exposure.

Pulmonary Oxygen Toxicity

The lungs are particularly vulnerable because the respiratory epithelium and pulmonary capillary endothelium are directly exposed to inspired oxygen. Pulmonary oxygen toxicity can range from mild airway irritation to diffuse alveolar injury resembling acute respiratory distress syndrome.

Early Airway Effects

Early symptoms may resemble inflammation of the tracheobronchial tree. An awake patient breathing a high oxygen concentration may experience:

• Substernal discomfort
• Chest tightness
• Dry cough
• Throat irritation
• Pain with deep inspiration
• Mild shortness of breath

Note: These symptoms are nonspecific and may be difficult to recognize in critically ill, sedated, or mechanically ventilated patients. Pulmonary injury may progress without the patient being able to report discomfort.

Alveolar-Capillary Membrane Injury

Reactive oxygen species damage the epithelial cells lining the alveoli and the endothelial cells lining the pulmonary capillaries. This disrupts the alveolar-capillary membrane, which normally provides a thin barrier for gas exchange.

As the membrane becomes more permeable, fluid and proteins move from the pulmonary circulation into the interstitial tissue and alveoli. This produces pulmonary edema and increases the distance that oxygen must travel to reach the blood.

Protein-rich fluid within the alveoli can interfere with surfactant activity, promote alveolar instability, and reduce the amount of lung available for effective gas exchange.

Inflammatory Response

Cellular injury activates an inflammatory response. Neutrophils, macrophages, platelets, and other inflammatory cells migrate into the damaged tissue. These cells release:

• Cytokines
• Proteolytic enzymes
• Additional reactive oxygen species
• Inflammatory mediators
• Substances that increase vascular permeability

Note: Although inflammation is intended to remove damaged cells and begin tissue repair, an excessive response can worsen the original injury. Oxidative stress and inflammation may reinforce one another, producing a continuing cycle of tissue damage.

Surfactant Dysfunction

Surfactant lowers surface tension within the alveoli and helps prevent collapse during exhalation. Damage to alveolar type II cells may reduce surfactant production and alter surfactant composition.

Reduced surfactant activity can cause:

• Increased alveolar surface tension
• Alveolar instability
• Reduced functional residual capacity
• Increased work of breathing
• Lower lung compliance
• Greater tendency toward atelectasis

Note: In mechanically ventilated patients, surfactant dysfunction may increase the pressure required to inflate the lungs.

Decreased Lung Compliance

As edema, inflammation, cellular debris, and alveolar collapse increase, the lungs become stiffer. This reduction in compliance means that more pressure is required to deliver a given tidal volume.

During volume-controlled ventilation, worsening compliance may appear as rising peak and plateau pressures. During pressure-controlled ventilation, the delivered tidal volume may decrease even though the pressure setting remains unchanged.

A decline in compliance can increase the work of breathing and contribute to patient-ventilator dyssynchrony. It may also require changes in ventilator settings to maintain adequate ventilation.

Worsening Gas Exchange

Pulmonary oxygen toxicity impairs gas exchange through several mechanisms:

• Alveolar flooding
• Interstitial edema
• Surfactant dysfunction
• Alveolar collapse
• Reduced lung compliance
• Ventilation-perfusion imbalance
• Increased physiologic shunting

Some lung regions may remain perfused even though they are poorly ventilated or completely collapsed. Blood passing through these areas does not become adequately oxygenated. This produces an intrapulmonary shunt.

Shunt-related hypoxemia often responds poorly to increases in FiO₂ because oxygen cannot reach blood flowing through nonventilated alveoli. Additional strategies, such as PEEP, positioning, recruitment, secretion removal, or treatment of the underlying disease, may be required.

The Cycle of Increasing Oxygen Requirements

One of the major clinical challenges of oxygen toxicity is that worsening lung injury can produce worsening hypoxemia. The natural response may be to increase the FiO₂. However, additional oxygen may intensify oxidative injury and inflammation.

This can produce a harmful cycle:

1. High FiO₂ contributes to lung injury.
2. Lung injury worsens ventilation-perfusion matching.
3. Shunting and hypoxemia increase.
4. The FiO₂ is increased further.
5. Oxidative damage becomes more severe.
6. The patient becomes increasingly dependent on high oxygen concentrations.

Note: Breaking this cycle requires correction of the underlying cause of hypoxemia and improvement in lung recruitment. The FiO₂ should be reduced when adequate oxygenation can be maintained by other means.

Concentration and Duration of Exposure

The relationship between oxygen concentration and toxicity is not defined by one exact threshold. However, several exposure levels are commonly used as warning points.

Sustained FiO₂ values greater than approximately 0.50 to 0.60 for 24 to 72 hours are associated with increased concern for pulmonary injury. The risk generally rises as the FiO₂ and exposure time increase.

Common clinical principles include:

• An FiO₂ approaching 1.00 may be necessary during resuscitation or severe hypoxemia.
• FiO₂ values above 0.60 should generally be considered temporary when possible.
• Exposure to more than 0.50 oxygen for 48 to 72 hours should prompt reassessment.
• FiO₂ values above approximately 0.80 increase the risk of absorption atelectasis.
• Patient susceptibility may alter the risk at any concentration.

Note: These values should not be interpreted as absolute cutoffs. Some patients tolerate prolonged oxygen exposure without obvious toxicity, while others develop injury sooner because of severe inflammation, mechanical ventilation, or preexisting lung disease.

Factors That Influence Susceptibility

The likelihood of oxygen toxicity differs among patients. Important contributing factors include:

• Age
• Prematurity
• Preexisting lung disease
• Sepsis
• Acute respiratory distress syndrome
• Nutritional deficiencies
• Reduced antioxidant capacity
• Mechanical ventilation
• High airway pressures
• Repeated alveolar opening and collapse
• Severe systemic inflammation
• Duration of critical illness
• Exposure to other pulmonary toxins

Mechanical ventilation may interact with hyperoxia. Overdistention, repetitive alveolar collapse, high pressures, and oxygen-derived free radicals can all increase alveolar-capillary membrane injury.

It may be difficult to determine how much damage is caused by oxygen and how much is caused by ventilator-induced lung injury because both processes may occur together.

Absorption Atelectasis

Absorption atelectasis is a separate complication of high oxygen exposure, although it can occur at the same time as oxygen toxicity and contribute to worsening oxygenation.

Role of Nitrogen in the Alveoli

Room air contains approximately 78% nitrogen. Nitrogen is poorly absorbed into the bloodstream, so it remains in the alveoli and helps maintain alveolar volume.

When a patient breathes a very high oxygen concentration, nitrogen is washed out of the lungs. Oxygen becomes the primary gas within the alveoli. Because oxygen is readily absorbed into the pulmonary circulation, alveolar gas volume may decline rapidly.

Note: If oxygen is absorbed faster than gas enters the alveolus, the alveolus becomes smaller and may collapse.

Airway Obstruction and Atelectasis

Absorption atelectasis is especially likely when an airway is partially or completely obstructed. Oxygen trapped beyond the obstruction is absorbed into the blood, but new gas cannot enter the alveolus. With little nitrogen remaining to maintain volume, the alveolus collapses.

Possible causes of obstruction include:

• Mucus plugs
• Airway swelling
• Tumors
• Foreign bodies
• Malpositioned artificial airways
• Severe bronchospasm
• Dependent airway closure

Note: Collapsed alveoli remain perfused but are no longer ventilated effectively. This increases shunting and may cause oxygenation to worsen despite the use of a high FiO₂.

Clinical Consequences

Absorption atelectasis can result in:

• Reduced functional residual capacity
• Lower lung compliance
• Increased shunt
• Worsening hypoxemia
• Increased work of breathing
• Greater dependence on positive pressure
• Reduced surface area for gas exchange

Note: Increasing FiO₂ further may provide limited benefit when the primary problem is alveolar collapse. Treatment should focus on restoring ventilation, recruiting the affected lung region, clearing obstruction, and stabilizing alveoli.

Positive End-Expiratory Pressure and CPAP

Positive end-expiratory pressure, or PEEP, is commonly used in mechanically ventilated patients to improve oxygenation and reduce dependence on high FiO₂. Continuous positive airway pressure, or CPAP, provides a similar effect in spontaneously breathing patients.

How PEEP Improves Oxygenation

PEEP maintains positive pressure in the lungs at the end of exhalation. This may:

• Increase functional residual capacity
• Stabilize previously unstable alveoli
• Reopen recruitable lung regions
• Reduce intrapulmonary shunting
• Improve ventilation-perfusion matching
• Increase the surface area available for gas exchange
• Permit a lower FiO₂

Note: A patient who remains hypoxemic after prolonged exposure to more than 50% oxygen may benefit from appropriate PEEP if alveolar collapse or reduced lung volume is contributing to the oxygenation problem.

Minimum-PEEP Approach

A minimum-PEEP strategy uses the lowest pressure that achieves acceptable oxygenation while allowing the FiO₂ to be reduced. A traditional goal is to maintain a PaO₂ above approximately 60 mm Hg or an SpO₂ above 90% while using an FiO₂ of 0.60 or less.

The best PEEP is not always the level that produces the highest PaO₂. Excessive PEEP may improve arterial oxygen values while reducing cardiac output and tissue perfusion. The goal is adequate oxygen delivery, not simply a higher PaO₂.

Risks of Excessive PEEP

PEEP must be adjusted carefully because excessive levels may cause:

• Alveolar overdistention
• Reduced venous return
• Decreased cardiac output
• Hypotension
• Tachycardia
• Reduced urine output
• Impaired tissue perfusion
• Pneumothorax
• Tension pneumothorax
• Subcutaneous emphysema
• Mediastinal emphysema
• Pulmonary interstitial emphysema in neonates

Note: Hemodynamic status should be evaluated before and after PEEP adjustments. Blood pressure, heart rate, urine output, oxygen saturation, airway pressures, and signs of perfusion should be monitored.

Oxygen Toxicity and Mechanical Ventilation

Mechanically ventilated patients may have several simultaneous risk factors for lung injury. Hyperoxia can occur alongside volutrauma, barotrauma, atelectrauma, and inflammation.

Volutrauma and Overdistention

Large tidal volumes or excessive inspiratory pressures can overstretch alveoli. Overdistention damages the alveolar epithelium and pulmonary capillary endothelium. When this occurs during high oxygen exposure, oxidative and mechanical injury may combine.

Atelectrauma

Repeated opening and closing of unstable alveoli creates shear stress. This can damage the alveolar-capillary membrane and release inflammatory mediators. Appropriate PEEP may reduce cyclic collapse, although excessive PEEP can cause overdistention.

Monitoring Changes in Compliance

Pulmonary oxygen toxicity may be suspected when a patient exposed to prolonged high FiO₂ develops:

• Increasing plateau pressures
• Decreasing tidal volumes
• Reduced static compliance
• Worsening hypoxemia
• Diffuse pulmonary infiltrates
• Increasing shunt
• Greater dependence on ventilatory support

Note: These findings are not specific to oxygen toxicity. They may also result from pulmonary edema, pneumonia, ARDS, atelectasis, pneumothorax, mucus plugging, or progression of the underlying disease.

Oxygen-Induced Hypercapnia

High oxygen concentrations may contribute to rising carbon dioxide levels in some patients, particularly those with chronic obstructive pulmonary disease or chronic carbon dioxide retention.

This effect is sometimes explained only as suppression of the hypoxic respiratory drive. However, several mechanisms may contribute.

Worsening Ventilation-Perfusion Matching

Hypoxic pulmonary vasoconstriction normally redirects blood away from poorly ventilated lung regions. High oxygen concentrations may reverse this response, causing more blood to flow through areas that eliminate carbon dioxide poorly.

This can increase ventilation-perfusion mismatch and raise PaCO₂.

Haldane Effect

Deoxygenated hemoglobin can carry more carbon dioxide than oxygenated hemoglobin. When oxygen therapy increases hemoglobin saturation, carbon dioxide may be displaced from hemoglobin into the plasma. This is known as the Haldane effect.

The displaced carbon dioxide can contribute to a rise in PaCO₂.

Changes in Ventilation

Some patients may experience a modest decrease in minute ventilation after receiving high oxygen concentrations. This can contribute to carbon dioxide retention, although it is usually not the only mechanism.

Oxygen should not be withheld from a severely hypoxemic patient because of fear of hypercapnia. Instead, oxygen should be titrated carefully while ventilation, mental status, respiratory effort, and arterial blood gases are monitored.

Central Nervous System Oxygen Toxicity

Central nervous system oxygen toxicity is most strongly associated with oxygen administered at pressures greater than normal atmospheric pressure. This occurs during hyperbaric oxygen therapy and certain diving exposures.

Signs and Symptoms

Possible manifestations include:

• Nausea
• Dizziness
• Visual changes
• Auditory changes
• Facial twitching
• Muscle twitching
• Irritability
• Anxiety
• Confusion
• Seizures

Seizures are one of the most serious manifestations. The risk increases as oxygen pressure rises and exposure time lengthens.

Central nervous system toxicity is less common during conventional oxygen administration at normal atmospheric pressure. In those situations, the lungs are usually the primary organs at risk.

Hyperbaric Safety

Hyperbaric oxygen therapy must be provided under controlled conditions. Treatment sessions use carefully selected oxygen pressures and exposure times. Patients require close observation, and personnel must be trained to recognize early neurologic symptoms.

Temporary interruptions in oxygen exposure may be used during some treatment protocols to reduce toxicity risk.

Retinopathy of Prematurity

Premature infants are especially vulnerable to oxygen-related retinal injury because retinal blood vessels are still developing.

Excessive oxygen may initially cause retinal vasoconstriction and interruption of normal vascular development. When oxygen levels later decline, abnormal new blood vessels may grow. These fragile vessels can bleed, form scar tissue, and pull on the retina.

Severe retinopathy of prematurity may result in:

• Retinal scarring
• Retinal detachment
• Visual impairment
• Blindness

Oxygen must be carefully titrated in premature infants. The goal is to provide sufficient oxygen for organ function while preventing unnecessary hyperoxemia and large fluctuations in oxygen saturation.

Arterial oxygen tensions above approximately 80 mm Hg have traditionally been avoided in vulnerable neonates, although modern neonatal care usually relies on carefully defined saturation targets and frequent monitoring.

Oxygen Toxicity in Neonatal Respiratory Care

Neonates with respiratory distress may require high oxygen concentrations, positive pressure, and surfactant therapy. Their management is especially challenging because both hypoxemia and excessive oxygen can cause harm.

Premature infants often have:

• Surfactant deficiency
• Low functional residual capacity
• Poor lung compliance
• Unstable alveoli
• Immature antioxidant systems
• Increased susceptibility to oxidative injury

Increasing FiO₂ alone may not adequately improve oxygenation when the primary problem is alveolar collapse. PEEP, CPAP, inspiratory pressure adjustments, changes in inspiratory time, recruitment, and surfactant replacement may be required.

Whenever possible, oxygen concentration and airway pressure should be adjusted one at a time. This makes it easier to determine which intervention produced the observed change.

Brief use of 100% oxygen may be necessary during severe neonatal hypoxemia or resuscitation. Prolonged exposure should be avoided when lower concentrations can maintain acceptable oxygenation.

Clinical Signs of Pulmonary Oxygen Toxicity

Early recognition can be difficult because the signs of oxygen toxicity overlap with those of many respiratory disorders.

Possible clinical findings include:

• Dry cough
• Chest discomfort
• Substernal pain
• Dyspnea
• Increased respiratory rate
• Reduced vital capacity
• Decreased lung compliance
• Increasing oxygen requirements
• Worsening hypoxemia
• Diffuse pulmonary infiltrates
• Increasing airway pressures
• Decreasing tidal volumes
• Crackles
• Signs of pulmonary edema

Note: No single finding confirms oxygen toxicity. Diagnosis is usually based on the pattern of oxygen exposure, clinical deterioration, exclusion of other causes, and response to reduced oxygen exposure when reduction is possible.

Monitoring Oxygen Therapy

Safe oxygen administration requires ongoing evaluation. A setting selected during an emergency should not remain unchanged without reassessment.

Pulse Oximetry

Pulse oximetry provides continuous or intermittent measurement of hemoglobin oxygen saturation. It is useful for tracking trends and detecting hypoxemia.

Limitations include:

• Poor perfusion
• Motion artifact
• Abnormal hemoglobin species
• Skin temperature
• Sensor placement
• Reduced accuracy at very low saturations

Note: Pulse oximetry does not directly measure PaO₂ or ventilation. A patient may have an acceptable saturation while experiencing severe hypercapnia or acid-base disturbance.

Arterial Blood Gas Analysis

Arterial blood gas analysis provides information about:

• PaO₂
• PaCO₂
• pH
• Bicarbonate
• Ventilation
• Acid-base status

The FiO₂ must be known accurately when interpreting PaO₂. Mechanically ventilated patients may require verification of the delivered FiO₂ using a calibrated internal or external oxygen analyzer.

After a clinically significant FiO₂ adjustment, oxygenation should be reassessed. The timing depends on the patient’s stability, the size of the change, and the urgency of the situation.

Respiratory Mechanics

In mechanically ventilated patients, clinicians should monitor:

• Peak inspiratory pressure
• Plateau pressure
• Static compliance
• Dynamic compliance
• Tidal volume
• Minute ventilation
• PEEP
• Flow patterns
• Patient-ventilator synchrony

Note: Worsening compliance or increasing pressure requirements may indicate progression of lung injury, although the cause must be investigated.

Hemodynamic and Perfusion Assessment

Adequate arterial oxygenation does not guarantee adequate tissue oxygen delivery. Monitoring should also include:

• Heart rate
• Blood pressure
• Cardiac output when available
• Mental status
• Skin temperature
• Capillary refill
• Urine output
• Lactate
• Venous oxygen saturation when indicated

Note: An intervention that raises PaO₂ but significantly reduces cardiac output may not improve overall oxygen delivery.

Oxygenation Targets

Oxygen targets should be individualized according to the patient’s disease, age, and clinical condition.

In many critically ill adults, commonly used targets include:

• PaO₂ of approximately 55 to 80 mm Hg
• SpO₂ of approximately 88% to 95%

Some patients require different goals. Patients with carbon monoxide poisoning, pregnancy, traumatic brain injury, severe anemia, or other special conditions may need individualized targets.

Patients with chronic hypercapnic respiratory disease are often managed with controlled oxygen therapy and lower saturation targets, commonly around 88% to 92%, depending on the clinical situation.

The lowest acceptable target is not necessarily appropriate for every patient. The treatment goal should reflect tissue oxygen needs, underlying disease, and the risks associated with both hypoxemia and hyperoxia.

Preventing Oxygen Toxicity

Prevention is based on limiting unnecessary oxygen exposure while maintaining adequate tissue oxygenation.

Use High FiO₂ When Necessary

High oxygen concentrations should be administered promptly during:

• Cardiac arrest
• Severe hypoxemia
• Major trauma
• Resuscitation
• Emergency intubation
• Carbon monoxide poisoning
• Severe respiratory failure
• Unstable transport
• Other life-threatening emergencies

Note: Fear of oxygen toxicity should never delay treatment of dangerous hypoxemia.

Reduce FiO₂ After Stabilization

Once the patient is stable, FiO₂ should be reassessed and reduced whenever possible. Oxygen requirements may change rapidly after:

• Intubation
• Suctioning
• Bronchodilator therapy
• PEEP adjustment
• Diuresis
• Recruitment
• Surfactant administration
• Positioning
• Treatment of infection
• Removal of airway obstruction

Note: Failure to reduce FiO₂ after improvement can expose the patient to unnecessary hyperoxia.

Treat the Cause of Hypoxemia

Persistent oxygen requirements should prompt investigation of the underlying problem. Possible causes include:

• Alveolar collapse
• Pulmonary edema
• Pneumonia
• ARDS
• Mucus plugging
• Pneumothorax
• Low cardiac output
• Pulmonary embolism
• Severe anemia
• Equipment malfunction
• Endotracheal tube displacement
• Inadequate ventilation
• Intracardiac or intrapulmonary shunting

Note: Increasing FiO₂ may provide temporary support, but it does not correct these conditions.

Improve Lung Recruitment

PEEP, CPAP, positioning, secretion removal, and recruitment strategies may improve the amount of aerated lung and allow FiO₂ reduction.

These interventions must be individualized. Aggressive recruitment or excessive pressure can produce overdistention, hypotension, or barotrauma.

Verify Oxygen Delivery

The delivered oxygen concentration should be confirmed, especially during mechanical ventilation. Oxygen analyzers should be calibrated according to manufacturer recommendations.

Equipment problems can result in a delivered FiO₂ that differs from the set value. Verification is important when arterial oxygen values do not match the expected response.

Treatment of Suspected Oxygen Toxicity

There is no specific antidote that immediately reverses pulmonary oxygen toxicity. Management focuses on reducing oxygen exposure when clinically possible and supporting gas exchange.

Potential interventions include:

• Lowering FiO₂ to the minimum effective concentration
• Applying appropriate PEEP or CPAP
• Using lung-protective ventilation
• Treating the underlying lung disease
• Clearing airway secretions
• Correcting fluid overload
• Improving hemodynamic status
• Treating infection or inflammation
• Monitoring respiratory mechanics
• Preventing further alveolar collapse

The FiO₂ should not be reduced to a level that causes dangerous hypoxemia. Reduction must occur gradually or promptly according to the patient’s response.

Some pulmonary changes may improve after oxygen exposure is reduced. Severe or prolonged injury may progress to fibrosis, pulmonary hypertension, and long-term impairment.

Potential Long-Term Complications

Severe oxygen-related lung injury may lead to:

• Persistent diffusion impairment
• Reduced lung compliance
• Pulmonary fibrosis
• Pulmonary hypertension
• Prolonged ventilator dependence
• Chronic exercise limitation
• Increased susceptibility to respiratory complications

Hyaline membranes may form along damaged alveolar surfaces during advanced diffuse alveolar injury. Fibroblasts may then deposit collagen and other structural material, producing fibrosis.

The likelihood of recovery depends on the severity of the injury, the duration of exposure, the patient’s underlying health, and whether other causes of lung damage are present.

Balancing Hypoxemia and Hyperoxia

The central challenge of oxygen therapy is balancing two competing risks.

Hypoxemia can rapidly cause:

• Cardiac arrhythmias
• Myocardial ischemia
• Neurologic injury
• Organ dysfunction
• Cardiac arrest
• Death

Hyperoxia usually causes injury over a longer period, although cardiovascular and neurologic effects can occur sooner under certain conditions.

The correct approach is not to avoid oxygen. It is to use oxygen precisely. High concentrations should be given when necessary, followed by frequent reassessment and reduction when the patient no longer requires them.

Oxygen therapy is most effective when it is individualized, monitored, and combined with treatment of the underlying cause of impaired oxygenation.

Oxygen Toxicity Practice Questions

1. What is oxygen toxicity?
Oxygen toxicity is tissue injury caused by exposure to an excessive oxygen concentration or partial pressure for a sufficient period.

2. Which two factors primarily determine the risk of oxygen toxicity?
The primary factors are the partial pressure or concentration of oxygen and the duration of exposure.

3. Which organ is most commonly affected during conventional high-oxygen therapy?
The lungs are most commonly affected because the alveoli and pulmonary capillaries are directly exposed to inspired oxygen.

4. What is the primary cellular cause of oxygen toxicity?
The primary cause is excessive production of reactive oxygen species that overwhelms the body’s antioxidant defenses.

5. What are reactive oxygen species?
Reactive oxygen species are highly reactive oxygen-derived molecules that can damage cell membranes, proteins, enzymes, lipids, and genetic material.

6. Name three reactive oxygen species associated with oxygen toxicity.
Examples include superoxide radicals, hydroxyl radicals, and hydrogen peroxide.

7. What normally protects the body from oxygen free radicals?
Antioxidant systems, including superoxide dismutase, catalase, and glutathione, normally neutralize oxygen free radicals.

8. How does oxygen toxicity affect the alveolar-capillary membrane?
It increases membrane permeability, allowing fluid and proteins to leak into the interstitial tissue and alveoli.

9. What pulmonary complication can result from increased alveolar-capillary permeability?
Pulmonary edema can develop as fluid accumulates in the interstitial and alveolar spaces.

10. How does damage to alveolar type II cells affect the lungs?
It can reduce surfactant production and weaken antioxidant protection within the lungs.

11. Why is surfactant important?
Surfactant reduces alveolar surface tension, improves lung compliance, and helps prevent alveolar collapse.

12. How does oxygen toxicity affect lung compliance?
It decreases lung compliance, causing the lungs to become stiffer and more difficult to inflate.

13. What happens to airway pressures when lung compliance worsens during volume-controlled ventilation?
Peak and plateau airway pressures may increase because more pressure is needed to deliver the set tidal volume.

14. How may worsening compliance appear during pressure-controlled ventilation?
The delivered tidal volume may decrease even though the inspiratory pressure remains unchanged.

15. Why can oxygen toxicity cause worsening hypoxemia?
Alveolar edema, inflammation, surfactant dysfunction, and collapse increase ventilation-perfusion mismatch and intrapulmonary shunting.

16. What is an intrapulmonary shunt?
An intrapulmonary shunt occurs when blood flows through nonventilated or poorly ventilated lung regions without becoming adequately oxygenated.

17. Why may increasing FiO₂ fail to correct severe shunt-related hypoxemia?
Oxygen cannot reach blood flowing through completely collapsed or fluid-filled alveoli, so the response to additional oxygen is limited.

18. What inspired oxygen range is traditionally associated with increased concern for pulmonary toxicity?
An FiO₂ of approximately 0.50 to 0.60 or greater for 24 to 72 hours raises concern for pulmonary oxygen toxicity.

19. Should high oxygen concentrations be withheld from a severely hypoxemic patient?
No. Severe hypoxemia must be corrected immediately, even if a high oxygen concentration is temporarily required.

20. What should be done after a severely hypoxemic patient becomes stable?
The FiO₂ should be reassessed and reduced to the lowest level that maintains adequate tissue oxygenation.

21. What is absorption atelectasis?
Absorption atelectasis is alveolar collapse caused when nitrogen is washed out and oxygen is absorbed from the alveoli faster than it is replaced.

22. How does nitrogen help maintain alveolar stability?
Nitrogen is absorbed slowly into the blood, so it remains in the alveoli and helps preserve alveolar volume.

23. At approximately what FiO₂ does the risk of absorption atelectasis become especially important?
The risk becomes particularly important when the FiO₂ exceeds approximately 0.80.

24. How can PEEP help reduce exposure to high oxygen concentrations?
PEEP recruits and stabilizes alveoli, improves functional residual capacity, reduces shunting, and may allow the FiO₂ to be lowered.

25. What is the main principle for preventing oxygen toxicity?
Use the lowest inspired oxygen concentration that provides adequate oxygenation while frequently reassessing the patient’s response.

26. What early symptom may occur in an awake patient exposed to a high oxygen concentration?
The patient may develop substernal discomfort, chest tightness, throat irritation, or a dry cough.

27. Why can pulmonary oxygen toxicity be difficult to recognize in sedated patients?
Sedated patients cannot report early symptoms such as chest discomfort, irritation, or difficulty taking a deep breath.

28. Which inflammatory cells commonly enter lung tissue after oxygen-related injury?
Neutrophils and macrophages commonly migrate into the injured lung tissue.

29. How can inflammatory cells worsen oxygen-related lung injury?
They can release additional reactive oxygen species, enzymes, cytokines, and other inflammatory mediators.

30. What may form along the alveolar surfaces during advanced oxygen-related lung injury?
Hyaline membranes may form along the damaged alveolar surfaces.

31. What chronic structural change may follow severe or prolonged pulmonary oxygen toxicity?
Pulmonary fibrosis may develop after extensive or prolonged injury.

32. How can severe oxygen toxicity contribute to pulmonary hypertension?
Persistent lung injury, inflammation, vascular changes, and fibrosis may increase resistance in the pulmonary circulation.

33. Why might a very high PaO₂ provide little additional benefit once hemoglobin is adequately saturated?
The upper portion of the oxyhemoglobin dissociation curve is relatively flat, so large increases in PaO₂ produce only small increases in oxygen content.

34. What cardiovascular effect can occur during significant hyperoxia?
Hyperoxia may cause vasoconstriction and reduce cardiac output in some patients.

35. How can hyperoxia affect cerebral blood flow?
It may cause cerebral vasoconstriction and reduce blood flow to the brain.

36. Why does a high PaO₂ not always guarantee adequate tissue oxygenation?
Tissue oxygenation also depends on hemoglobin concentration, cardiac output, blood flow, and cellular oxygen extraction.

37. Which patient factor can increase susceptibility to oxygen toxicity by reducing the ability to neutralize free radicals?
Poor antioxidant capacity can increase susceptibility to oxygen toxicity.

38. How can poor nutritional status influence the risk of oxygen toxicity?
Nutritional deficiencies may weaken antioxidant defenses and make tissues more vulnerable to oxidative injury.

39. How can mechanical ventilation increase the risk of lung injury during high oxygen exposure?
Overdistention, elevated airway pressures, and repeated alveolar opening and collapse may combine with oxidative injury.

40. What is atelectrauma?
Atelectrauma is lung injury caused by the repeated opening and closing of unstable alveoli.

41. What is volutrauma?
Volutrauma is lung injury caused by excessive tidal volume and alveolar overdistention.

42. What oxygenation goal is commonly used when applying a minimum-PEEP approach?
A common goal is a PaO₂ above approximately 60 mm Hg or an SpO₂ above 90% while using an FiO₂ of 0.60 or less.

43. Why is the PEEP level that produces the highest PaO₂ not always the best setting?
Excessive PEEP may improve PaO₂ while reducing cardiac output and overall tissue perfusion.

44. How can excessive PEEP reduce cardiac output?
It increases intrathoracic pressure, decreases venous return, and reduces ventricular filling.

45. What hemodynamic signs may indicate that PEEP is too high?
Hypotension, tachycardia, reduced urine output, and signs of poor tissue perfusion may occur.

46. Name two forms of barotrauma associated with excessive airway pressure.
Pneumothorax and subcutaneous emphysema are two possible forms of barotrauma.

47. Why should urine output be monitored after increasing PEEP?
Reduced urine output may indicate decreased cardiac output and impaired renal perfusion.

48. What is refractory hypoxemia?
Refractory hypoxemia is severe low arterial oxygenation that responds poorly to increases in inspired oxygen.

49. Why might increasing FiO₂ not proportionally increase PaO₂ in a patient with ARDS?
A large amount of blood may be flowing through collapsed, fluid-filled, or nonventilated alveoli.

50. What should clinicians address when increasing FiO₂ does not adequately improve oxygenation?
They should investigate shunting, alveolar collapse, secretion obstruction, reduced lung volume, and the underlying lung disease.

51. Which device provides continuous information about hemoglobin oxygen saturation?
Pulse oximetry provides continuous or intermittent measurement of oxygen saturation.

52. What does arterial blood gas analysis measure that pulse oximetry does not?
It directly measures PaO₂, PaCO₂, and pH while also providing information about acid-base status.

53. Why must the delivered FiO₂ be known when interpreting an arterial blood gas?
PaO₂ must be evaluated in relation to the oxygen concentration the patient is receiving.

54. How can clinicians verify the FiO₂ delivered by a mechanical ventilator?
They can use a calibrated internal oxygen analyzer or an external oxygen analyzer.

55. What should occur after a clinically significant change in FiO₂?
The patient’s oxygenation should be reassessed to confirm that the adjustment produced the intended response.

56. Why should oxygen therapy not remain at a fixed setting after an emergency?
The patient’s oxygen requirement may decrease, making the original setting unnecessarily high and potentially harmful.

57. What oxygen saturation range is often targeted in critically ill adults?
A commonly used target range is approximately 88% to 95%.

58. What PaO₂ range is often considered acceptable in many critically ill adults?
A PaO₂ of approximately 55 to 80 mm Hg is often considered acceptable.

59. Why should oxygen targets be individualized?
Underlying disease, age, tissue oxygen needs, carbon dioxide retention, and clinical condition may require different targets.

60. How can high oxygen concentrations worsen ventilation-perfusion matching in susceptible patients?
They may reverse hypoxic pulmonary vasoconstriction and increase blood flow to poorly ventilated lung regions.

61. What is hypoxic pulmonary vasoconstriction?
It is the narrowing of pulmonary blood vessels in poorly ventilated regions to redirect blood toward better-ventilated alveoli.

62. What is the Haldane effect?
The Haldane effect describes the reduced ability of oxygenated hemoglobin to carry carbon dioxide, causing more carbon dioxide to enter the plasma.

63. How can the Haldane effect contribute to oxygen-induced hypercapnia?
As hemoglobin becomes more oxygenated, carbon dioxide is displaced into the blood and may increase PaCO₂.

64. Should oxygen be withheld from a patient with chronic carbon dioxide retention who is severely hypoxemic?
No. Hypoxemia should be corrected while oxygen is carefully titrated and ventilation is closely monitored.

65. Which findings should be monitored when oxygen-induced hypercapnia is a concern?
PaCO₂, pH, respiratory effort, mental status, respiratory rate, and oxygen saturation should be monitored.

66. In what setting is central nervous system oxygen toxicity most likely to occur?
It is most likely during hyperbaric oxygen therapy or other exposure to oxygen at increased atmospheric pressure.

67. What serious neurologic complication may result from central nervous system oxygen toxicity?
Seizures may occur during excessive hyperbaric oxygen exposure.

68. What early neurologic symptom may precede a hyperoxic seizure?
Facial or muscle twitching may occur before a seizure.

69. Why are treatment periods carefully controlled during hyperbaric oxygen therapy?
Limiting oxygen pressure and exposure duration reduces the risk of central nervous system toxicity.

70. Why are premature infants especially sensitive to oxygen toxicity?
They have developing organs, immature antioxidant defenses, and incompletely developed retinal blood vessels.

71. How does excessive oxygen contribute to retinopathy of prematurity?
It disrupts normal retinal blood vessel development and can trigger abnormal vessel growth and scarring.

72. What severe visual complication can result from retinopathy of prematurity?
Retinal detachment and permanent visual impairment may occur.

73. Why should large fluctuations in neonatal oxygen levels be avoided?
Rapid changes can interfere with retinal vascular development and increase oxidative stress.

74. Why may FiO₂ alone fail to improve oxygenation in neonatal respiratory distress syndrome?
Surfactant deficiency and alveolar collapse may prevent adequate ventilation of the lungs.

75. What therapy may directly address surfactant deficiency in premature infants?
Exogenous surfactant replacement therapy may improve alveolar stability and oxygenation.

76. Why should oxygen concentration and airway pressure often be adjusted one at a time in neonatal care?
Changing one variable at a time helps clinicians identify which intervention caused the change in oxygenation.

77. What respiratory change may indicate worsening oxygen-related lung injury during volume-controlled ventilation?
A rising plateau pressure may indicate decreasing lung compliance and worsening alveolar injury.

78. What imaging finding may appear with severe pulmonary oxygen toxicity?
Diffuse bilateral pulmonary infiltrates may appear as edema and alveolar injury progress.

79. Why is oxygen toxicity considered a diagnosis of exclusion?
Its signs overlap with ARDS, pneumonia, pulmonary edema, atelectasis, and other causes of respiratory deterioration.

80. What should be investigated if a patient’s oxygen requirement suddenly increases?
Clinicians should evaluate for airway obstruction, tube displacement, pneumothorax, pulmonary edema, atelectasis, infection, or equipment malfunction.

81. How can mucus plugging increase dependence on supplemental oxygen?
A mucus plug may block ventilation to part of the lung, causing atelectasis, shunting, and worsening hypoxemia.

82. How can secretion removal help reduce FiO₂ requirements?
Clearing secretions can restore ventilation to obstructed lung regions and improve ventilation-perfusion matching.

83. How may patient positioning improve oxygenation?
Positioning can improve lung expansion, redistribute ventilation and perfusion, and recruit better-functioning lung regions.

84. What is the main treatment for suspected pulmonary oxygen toxicity?
The main treatment is reducing oxygen exposure to the lowest safe level while supporting ventilation and treating the underlying disorder.

85. Is there a specific antidote for pulmonary oxygen toxicity?
No. Management is supportive and focuses on limiting further exposure and maintaining adequate gas exchange.

86. Can pulmonary oxygen toxicity improve after FiO₂ is reduced?
Yes. Some inflammatory and functional changes may improve when excessive oxygen exposure is stopped early enough.

87. What factors influence recovery from oxygen-related lung injury?
Recovery depends on injury severity, exposure duration, underlying disease, age, and the presence of additional lung damage.

88. How can pulmonary fibrosis affect long-term respiratory function?
Fibrosis can reduce lung compliance, impair diffusion, limit exercise tolerance, and cause persistent breathing difficulty.

89. Why may prolonged oxygen toxicity increase ventilator dependence?
Stiff lungs, impaired gas exchange, inflammation, and fibrosis may make spontaneous breathing and ventilator weaning more difficult.

90. How can elevated oxygen levels affect coronary blood flow?
Hyperoxia may cause coronary vasoconstriction and reduce blood flow to the heart muscle.

91. Why may severe anemia cause poor tissue oxygenation despite a high PaO₂?
Most oxygen is carried by hemoglobin, so a low hemoglobin concentration limits oxygen content even when dissolved oxygen is high.

92. What role does cardiac output play in tissue oxygen delivery?
Cardiac output determines how much oxygenated blood is transported to the tissues each minute.

93. Why should lactate be assessed when evaluating tissue oxygenation?
An elevated lactate level may indicate inadequate tissue perfusion or oxygen utilization despite acceptable arterial oxygen values.

94. How may hyperoxia affect skeletal muscle blood flow?
Hyperoxia-induced vasoconstriction may reduce blood flow to skeletal muscles.

95. Why should clinicians avoid maintaining an SpO₂ of 100% without a specific reason?
An SpO₂ of 100% may correspond to a very high PaO₂ and unnecessary oxygen exposure without a meaningful increase in oxygen content.

96. What is denitrogenation?
Denitrogenation is the removal or washout of nitrogen from the alveoli during breathing of a high oxygen concentration.

97. How does alveolar collapse increase the work of breathing?
Fewer alveoli remain open, lung compliance decreases, and greater effort or pressure is required to inflate the lungs.

98. Why can oxygen toxicity resemble acute respiratory distress syndrome?
Both conditions can cause diffuse alveolar damage, edema, decreased compliance, shunting, pulmonary infiltrates, and severe hypoxemia.

99. What is the priority when deciding between preventing hyperoxia and treating severe hypoxemia?
Correcting severe hypoxemia is the immediate priority, followed by reducing oxygen exposure as soon as safely possible.

100. What overall approach supports the safest use of oxygen therapy?
Oxygen should be individually titrated, continuously monitored, frequently reassessed, and combined with treatment of the underlying cause of impaired oxygenation.

Final Thoughts

Oxygen toxicity is a dose- and time-dependent injury caused largely by excessive production of reactive oxygen species. Pulmonary effects include inflammation, alveolar-capillary membrane damage, edema, surfactant dysfunction, reduced compliance, shunting, and worsening hypoxemia.

High oxygen concentrations can also promote absorption atelectasis, contribute to hypercapnia in susceptible patients, injure the central nervous system during hyperbaric exposure, and damage the developing retina in premature infants.

Severe hypoxemia must always be treated immediately, but oxygen should be reassessed frequently and reduced to the lowest concentration that maintains adequate tissue oxygenation.